Home/Filings/4/0000950170-24-027128
4//SEC Filing

Emany Sravan Kumar 4

Accession 0000950170-24-027128

CIK 0001446847other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:05 PM ET

Size

4.9 KB

Accession

0000950170-24-027128

Insider Transaction Report

Form 4
Period: 2024-03-04
Emany Sravan Kumar
SVP, Chief Financial Officer
Transactions
  • Purchase

    Class A Common Stock

    2024-03-04$9.38/sh+10,684$100,216301,733 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.37 to $9.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001897662

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:05 PM ET
Size
4.9 KB